{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:02:32Z","timestamp":1790960552517,"version":"4.1.0"},"reference-count":240,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:00Z","timestamp":1597795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Systemic sclerosis (SSc) is a multisystem autoimmune and vascular disease resulting in fibrosis of various organs with unknown etiology. Accumulating evidence suggests that a common pathologic cascade across multiple organs and additional organ-specific pathologies underpin SSc development. The common pathologic cascade starts with vascular injury due to autoimmune attacks and unknown environmental factors. After that, dysregulated angiogenesis and defective vasculogenesis promote vascular structural abnormalities, such as capillary loss and arteriolar stenosis, while aberrantly activated endothelial cells facilitate the infiltration of circulating immune cells into perivascular areas of various organs. Arteriolar stenosis directly causes pulmonary arterial hypertension, scleroderma renal crisis and digital ulcers. Chronic inflammation persistently activates interstitial fibroblasts, leading to the irreversible fibrosis of multiple organs. The common pathologic cascade interacts with a variety of modifying factors in each organ, such as keratinocytes and adipocytes in the skin, esophageal stratified squamous epithelia and myenteric nerve system in gastrointestinal tract, vasospasm of arterioles in the heart and kidney, and microaspiration of gastric content in the lung. To better understand SSc pathogenesis and develop new disease-modifying therapies, it is quite important to understand the complex pathogenesis of SSc from the two distinct perspectives, namely the common pathologic cascade and additional organ-specific pathologies.<\/jats:p>","DOI":"10.3390\/jcm9092687","type":"journal-article","created":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T21:37:40Z","timestamp":1597873060000},"page":"2687","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":118,"title":["The Pathogenesis of Systemic Sclerosis: An Understanding Based on a Common Pathologic Cascade across Multiple Organs and Additional Organ-Specific Pathologies"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5560-9778","authenticated-orcid":false,"given":"Yoshihide","family":"Asano","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,8,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/1346-8138.14153","article-title":"Systemic sclerosis","volume":"45","author":"Asano","year":"2018","journal-title":"J. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S","article-title":"Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts","volume":"44","author":"Arnett","year":"2001","journal-title":"Arthritis Rheum."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/art.11173","article-title":"Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies","volume":"48","author":"Medsger","year":"2003","journal-title":"Arthritis Rheum"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrrheum.2014.128","article-title":"The role of genetics and epigenetics in the pathogenesis of systemic sclerosis","volume":"10","author":"Broen","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Yamashita, K., Kawasaki, A., Matsushita, T., Furukawa, H., Kondo, Y., Okiyama, N., Nagaoka, S., Shimada, K., Sugii, S., and Katayama, M. (2020). Association of functional (GA)n microsatellite polymorphism in the FLI1 gene with susceptibility to human systemic sclerosis. Rheumatology.","DOI":"10.1093\/rheumatology\/keaa306"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/art.24183","article-title":"Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: A new perspective for pulmonary fibrosis","volume":"60","author":"Guedj","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/art.24600","article-title":"Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population","volume":"60","author":"Ito","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3899\/jrheum.091163","article-title":"Phenotype-haplotype correlation of IRF5 in systemic sclerosis: Role of 2 haplotypes in disease severity","volume":"37","author":"Dieude","year":"2010","journal-title":"J. Rheumatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ng.565","article-title":"Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus","volume":"42","author":"Radstake","year":"2010","journal-title":"Nat. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.4238\/2014.June.16.6","article-title":"Association between IRF5 polymorphisms and autoimmune diseases: A meta-analysis","volume":"13","author":"Tang","year":"2014","journal-title":"Genet. Mol. Res."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Allanore, Y., Saad, M., Dieud\u00e9, P., Avouac, J., Distler, J.H., Amouyel, P., Matucci-Cerinic, M., Riemekasten, G., Airo, P., and Melchers, I. (2011). Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis. PLoS Genet., 7.","DOI":"10.1371\/journal.pgen.1002091"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1136\/annrheumdis-2011-200901","article-title":"IRF5 polymorphism predicts prognosis in patients with systemic sclerosis","volume":"71","author":"Sharif","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1586\/1744666X.2016.1125782","article-title":"An overview of environmental risk factors in systemic sclerosis","volume":"12","author":"Ciccarelli","year":"2016","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/art.39476","article-title":"Identification of an Association of TNFAIP3 Polymorphisms With Matrix Metalloproteinase Expression in Fibroblasts in an Integrative Study of Systemic Sclerosis-Associated Genetic and Environmental Factors","volume":"68","author":"Wei","year":"2016","journal-title":"Arthritis Rheum."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00281-015-0504-6","article-title":"Epigenetics and systemic sclerosis","volume":"37","author":"Altorok","year":"2015","journal-title":"Semin Immunopathol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Burbelo, P.D., Gordon, S.M., Waldman, M., Edison, J.D., Little, D.J., Stitt, R.S., Bailey, W.T., Hughes, J.B., and Olson, S.W. (2019). Autoantibodies are present before the clinical diagnosis of systemic sclerosis. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0214202"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.2010.136929","article-title":"Preliminary criteria for the very early diagnosis of systemic sclerosis: Results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group","volume":"70","author":"Avouac","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1006\/clim.1999.4694","article-title":"Gammadelta receptor bearing T cells in scleroderma: Enhanced interaction with vascular endothelial cells in vitro","volume":"91","author":"Kahaleh","year":"1999","journal-title":"Clin. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1365-2249.1996.d01-867.x","article-title":"Antibodies to membranes of endothelial cells and fibroblasts in scleroderma","volume":"106","author":"Hill","year":"1996","journal-title":"Clin. Exp. Immunol."},{"key":"ref_22","first-page":"450","article-title":"Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases","volume":"72","author":"Rosenbaum","year":"1988","journal-title":"Clin. Exp. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0002-9343(96)00404-4","article-title":"Antiendothelial cell antibodies: Useful markers of systemic sclerosis","volume":"102","author":"Salojin","year":"1997","journal-title":"Am. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H","article-title":"Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95","volume":"43","author":"Sgonc","year":"2000","journal-title":"Arthritis Rheum."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/rheumatology\/keu479","article-title":"Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis","volume":"54","author":"Akamata","year":"2015","journal-title":"Rheumatology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/art.23451","article-title":"Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma","volume":"58","author":"Duan","year":"2008","journal-title":"Arthritis Rheum."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/bjd.14699","article-title":"A potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and vasculopathy in systemic sclerosis","volume":"175","author":"Takahashi","year":"2016","journal-title":"Br. J. Dermatol"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Toyama, T., Asano, Y., Miyagawa, T., Nakamura, K., Hirabayashi, M., Yamashita, T., Saigusa, R., Miura, S., Ichimura, Y., and Takahashi, T. (2017). The impact of transcriptional factor Fli1 deficiency on the regulation of angiogenesis. Exp. Dermatol.","DOI":"10.1111\/exd.13341"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.2353\/ajpath.2010.090593","article-title":"Endothelial Fli1 deficiency impairs vascular homeostasis: A role in scleroderma vasculopathy","volume":"176","author":"Asano","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Kuwana, M., and Okazaki, Y. (2013). Impaired in vivo neovascularization capacity of endothelial progenitor cells in patients with systemic sclerosis. Arthritis Rheum.","DOI":"10.1002\/art.38326"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"R205","DOI":"10.1186\/ar3180","article-title":"Enhanced angiogenic potency of monocytic endothelial progenitor cells in patients with systemic sclerosis","volume":"12","author":"Yamaguchi","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(04)16853-0","article-title":"Defective vasculogenesis in systemic sclerosis","volume":"364","author":"Kuwana","year":"2004","journal-title":"Lancet"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.4049\/jimmunol.0901778","article-title":"Cell adhesion molecules regulate fibrotic process via Th1\/Th2\/Th17 cell balance in a bleomycin-induced scleroderma model","volume":"185","author":"Yoshizaki","year":"2010","journal-title":"J. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/art.38948","article-title":"Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated fli-1-haploinsufficient mice","volume":"67","author":"Taniguchi","year":"2015","journal-title":"Arthritis Rheum."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1186\/ar3066","article-title":"Characterization of monocyte\/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis","volume":"12","author":"Jinnin","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3109\/s10165-012-0813-8","article-title":"Dermal mast cell density in fingers reflects severity of skin sclerosis in systemic sclerosis","volume":"23","author":"Yukawa","year":"2013","journal-title":"Mod. Rheumatol"},{"key":"ref_37","first-page":"275","article-title":"Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: Association of interleukin 12 elevation with spontaneous regression of skin sclerosis","volume":"33","author":"Matsushita","year":"2006","journal-title":"J. Rheumatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/ar4430","article-title":"Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction","volume":"16","author":"Yang","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/rheumatology\/kei244","article-title":"Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients","volume":"45","author":"Tan","year":"2006","journal-title":"Rheumatology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2353\/ajpath.2009.090698","article-title":"Endothelial-mesenchymal transition as a novel mechanism for generating myofibroblasts during diabetic nephropathy","volume":"175","author":"Kizu","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm1613","article-title":"Endothelial-to-mesenchymal transition contributes to cardiac fibrosis","volume":"13","author":"Zeisberg","year":"2007","journal-title":"Nat. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.2353\/ajpath.2009.090096","article-title":"Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice","volume":"175","author":"Li","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1165\/rcmb.2009-0031OC","article-title":"Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis","volume":"43","author":"Hashimoto","year":"2010","journal-title":"Am. J. Respir Cell Mol. Biol"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"835948","DOI":"10.1155\/2013\/835948","article-title":"Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis","volume":"2013","author":"Jimenez","year":"2013","journal-title":"ISRN Rheumatol"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.matbio.2016.01.012","article-title":"Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?","volume":"51","author":"Jimenez","year":"2016","journal-title":"Matrix Biol"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/art.39421","article-title":"Endothelial Cells Expressing Endothelial and Mesenchymal Cell Gene Products in Lung Tissue From Patients With Systemic Sclerosis-Associated Interstitial Lung Disease","volume":"68","author":"Mendoza","year":"2016","journal-title":"Arthritis Rheum."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/annrheumdis-2016-210229","article-title":"Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis","volume":"76","author":"Manetti","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_48","first-page":"1566","article-title":"Significance of plasma endothelin-1 levels in patients with systemic sclerosis","volume":"19","author":"Yamane","year":"1992","journal-title":"J. Rheumatol."},{"key":"ref_49","first-page":"1838","article-title":"Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?","volume":"21","author":"Vancheeswaran","year":"1994","journal-title":"J. Rheumatol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Marvi, U., and Chung, L. (2010). Digital ischemic loss in systemic sclerosis. Int. J. Rheumatol., 2010.","DOI":"10.1155\/2010\/130717"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/bjd.14183","article-title":"Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: A possible role in prothrombotic conditions","volume":"174","author":"Saigusa","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"ref_52","first-page":"392","article-title":"Plasma D-dimer concentration in patients with systemic sclerosis","volume":"158","author":"Marie","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1477-9560-4-2","article-title":"Plasma D-dimer concentration in patients with systemic sclerosis","volume":"4","author":"Lippi","year":"2006","journal-title":"Thromb. J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/rheumatology\/keg071","article-title":"Plasma plasmin-alpha2-plasmin inhibitor complex levels are increased in systemic sclerosis patients with pulmonary hypertension","volume":"42","author":"Jinnin","year":"2003","journal-title":"Rheumatology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00002281-199411000-00013","article-title":"Raynaud\u2019s phenomenon and vascular disease in scleroderma","volume":"6","author":"Kahaleh","year":"1994","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.autrev.2005.08.004","article-title":"Digital ulcers in patients with systemic sclerosis","volume":"5","author":"Chung","year":"2006","journal-title":"Autoimmun. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Schiopu, E., Impens, A.J., and Phillips, K. (2010). Digital ischemia in scleroderma spectrum of diseases. Int. J. Rheumatol., 2010.","DOI":"10.1155\/2010\/923743"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e946","DOI":"10.1016\/j.jaci.2014.12.1932","article-title":"Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis","volume":"135","author":"MacDonald","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13075-018-1569-0","article-title":"Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression","volume":"20","author":"Bosello","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1002\/art.22847","article-title":"B cell infiltration in systemic sclerosis-associated interstitial lung disease","volume":"56","author":"Lafyatis","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"12319","DOI":"10.1073\/pnas.1635114100","article-title":"Systemic and cell type-specific gene expression patterns in scleroderma skin","volume":"100","author":"Whitfield","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jdermsci.2008.01.001","article-title":"Clinical association of serum interleukin-17 levels in systemic sclerosis: Is systemic sclerosis a Th17 disease?","volume":"50","author":"Murata","year":"2008","journal-title":"J. Dermatol. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.humimm.2014.12.008","article-title":"The elevated expression of Th17-related cytokines and receptors is associated with skin lesion severity in early systemic sclerosis","volume":"76","author":"Zhou","year":"2015","journal-title":"Hum. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.3389\/fimmu.2018.02356","article-title":"Regulatory T Cells in Systemic Sclerosis","volume":"9","author":"Frantz","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0923-1811(01)00128-1","article-title":"Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis","volume":"27","author":"Sato","year":"2001","journal-title":"J. Dermatol. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.4049\/jimmunol.1100591","article-title":"Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts","volume":"188","author":"Nakashima","year":"2012","journal-title":"J. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/1346-8138.13184","article-title":"B lymphocytes in systemic sclerosis: Abnormalities and therapeutic targets","volume":"43","author":"Yoshizaki","year":"2016","journal-title":"J. Dermatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.4049\/jimmunol.165.11.6635","article-title":"Quantitative genetic variation in CD19 expression correlates with autoimmunity","volume":"165","author":"Sato","year":"2000","journal-title":"J. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/art.20274","article-title":"Altered blood B lymphocyte homeostasis in systemic sclerosis: Expanded naive B cells and diminished but activated memory B cells","volume":"50","author":"Sato","year":"2004","journal-title":"Arthritis Rheum."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/ard.2008.095463","article-title":"Rituximab in diffuse cutaneous systemic sclerosis: An open-label clinical and histopathological study","volume":"69","author":"Smith","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/rheumatology\/kep093","article-title":"Experience with rituximab in scleroderma: Results from a 1-year, proof-of-principle study","volume":"49","author":"Daoussis","year":"2010","journal-title":"Rheumatology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1136\/annrheumdis-2013-204522","article-title":"Effects and safety of rituximab in systemic sclerosis: An analysis from the European Scleroderma Trial and Research (EUSTAR) group","volume":"74","author":"Jordan","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Daoussis, D., Melissaropoulos, K., Sakellaropoulos, G., Antonopoulos, I., Markatseli, T.E., Simopoulou, T., Georgiou, P., Andonopoulos, A.P., Drosos, A.A., and Sakkas, L. (2016). A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease. Semin Arthritis Rheum.","DOI":"10.1016\/j.semarthrit.2016.10.003"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.semarthrit.2014.09.002","article-title":"Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis","volume":"44","author":"Bosello","year":"2015","journal-title":"Semin Arthritis Rheum."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Ebata, S., Yoshizaki, A., Fukasawa, T., Miura, S., Takahashi, T., Sumida, H., Asano, Y., and Sato, S. (2019). Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti-topoisomerase I-positive systemic sclerosis-associated interstitial lung disease. J. Dermatol.","DOI":"10.1111\/1346-8138.15079"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.semarthrit.2011.11.007","article-title":"Treatment of systemic sclerosis-associated calcinosis: A case report of rituximab-induced regression of CREST-related calcinosis and review of the literature","volume":"41","author":"Daoussis","year":"2012","journal-title":"Semin Arthritis Rheum."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s10067-014-2579-1","article-title":"Rituximab for refractory digital infarcts and ulcers in systemic sclerosis","volume":"33","author":"Khor","year":"2014","journal-title":"Clin. Rheumatol."},{"key":"ref_78","first-page":"S228","article-title":"Effects of rituximab therapy on elastic properties of vascular wall in patients with progressive systemic sclerosis","volume":"32","author":"Maslyanskiy","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/art.30190","article-title":"Mast cells are a source of transforming growth factor \u03b2 in systemic sclerosis","volume":"63","author":"Hogan","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/S0140-6736(16)00232-4","article-title":"Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): A phase 2, randomised, controlled trial","volume":"387","author":"Khanna","year":"2016","journal-title":"Lancet"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/art.23486","article-title":"Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: Association of higher interferon-alpha activity with lung fibrosis","volume":"58","author":"Kim","year":"2008","journal-title":"Arthritis Rheum."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/1529-0131(199902)42:2<299::AID-ANR12>3.0.CO;2-R","article-title":"Interferon-alpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: Results of a randomized, double-blind, placebo-controlled trial","volume":"42","author":"Black","year":"1999","journal-title":"Arthritis Rheum."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/ard.2007.083246","article-title":"Sclerosing skin disorders in association with multiple sclerosis. Coincidence, underlying autoimmune pathology or interferon induced?","volume":"68","author":"Gratzl","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00296-006-0282-5","article-title":"Multiple sclerosis associated with systemic sclerosis","volume":"27","author":"Pelidou","year":"2007","journal-title":"Rheumatol. Int."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s004150050390","article-title":"Systemic sclerosis and multiple sclerosis","volume":"246","author":"Spadaro","year":"1999","journal-title":"J. Neurol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2169\/internalmedicine.46.6328","article-title":"Systemic sclerosis after interferon alphacon-1 therapy for hepatitis C","volume":"46","author":"Tahara","year":"2007","journal-title":"Intern. Med."},{"key":"ref_87","first-page":"625","article-title":"Systemic sclerosis developing in association with the use of interferon alpha therapy for chronic viral hepatitis","volume":"22","author":"Solans","year":"2004","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-2133.2002.48901.x","article-title":"Systemic sclerosis after interferon-alfa therapy for myeloproliferative disorders","volume":"147","author":"Beretta","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/labinvest.3700461","article-title":"Interferon-alpha prevents apoptosis of endothelial cells after short-term exposure but induces replicative senescence after continuous stimulation","volume":"86","author":"Pammer","year":"2006","journal-title":"Lab. Investig."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Ah Kioon, M.D., Tripodo, C., Fernandez, D., Kirou, K.A., Spiera, R.F., Crow, M.K., Gordon, J.K., and Barrat, F.J. (2018). Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8. Sci. Transl. Med., 10.","DOI":"10.1126\/scitranslmed.aam8458"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-1536-4-15","article-title":"Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: Reversal by caveolin-1 scaffolding domain peptide","volume":"4","author":"Tourkina","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Nikitorowicz-Buniak, J., Denton, C.P., Abraham, D., and Stratton, R. (2015). Partially Evoked Epithelial-Mesenchymal Transition (EMT) Is Associated with Increased TGF\u03b2 Signaling within Lesional Scleroderma Skin. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0134092"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/art.38990","article-title":"Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors","volume":"67","author":"Marangoni","year":"2015","journal-title":"Arthritis Rheum."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/1523-1747.ep12874503","article-title":"Transcription and expression of transforming growth factor type beta in the skin of progressive systemic sclerosis: A mediator of fibrosis?","volume":"94","author":"Gruschwitz","year":"1990","journal-title":"J. Investig. Dermatol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0923-1811(99)00008-0","article-title":"Expression of TGF-beta 1, -beta 2 and -beta 3 in localized and systemic scleroderma","volume":"21","author":"Querfeld","year":"1999","journal-title":"J. Dermatol. Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1172\/JCI114793","article-title":"Co-localization of transforming growth factor beta 2 with alpha 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis","volume":"86","author":"Kulozik","year":"1990","journal-title":"J. Clin. Investig."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI16269","article-title":"Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts","volume":"113","author":"Asano","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"7708","DOI":"10.4049\/jimmunol.175.11.7708","article-title":"Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts","volume":"175","author":"Asano","year":"2005","journal-title":"J. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0002-9440(10)63215-4","article-title":"Increased expression levels of integrin alphavbeta5 on scleroderma fibroblasts","volume":"164","author":"Asano","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1002\/art.21246","article-title":"Involvement of alphavbeta5 integrin-mediated activation of latent transforming growth factor beta1 in autocrine transforming growth factor beta signaling in systemic sclerosis fibroblasts","volume":"52","author":"Asano","year":"2005","journal-title":"Arthritis Rheum."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2353\/ajpath.2006.041306","article-title":"Increased expression of integrin alphavbeta5 induces the myofibroblastic differentiation of dermal fibroblasts","volume":"168","author":"Asano","year":"2006","journal-title":"Am. J. Pathol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0002-9440(10)62362-0","article-title":"Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-beta signaling in cultured scleroderma fibroblasts","volume":"166","author":"Mimura","year":"2005","journal-title":"Am. J. Pathol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1002\/1529-0131(199811)41:11<2039::AID-ART20>3.0.CO;2-1","article-title":"Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: Different sensitivity to inhibition between systemic sclerosis and control fibroblasts","volume":"41","author":"Chizzolini","year":"1998","journal-title":"Arthritis Rheum."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1002\/art.11129","article-title":"Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha","volume":"48","author":"Chizzolini","year":"2003","journal-title":"Arthritis Rheum."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1002\/art.39312","article-title":"Progranulin Overproduction Due to Fli-1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor in Systemic Sclerosis","volume":"67","author":"Ichimura","year":"2015","journal-title":"Arthritis Rheum."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.jid.2017.04.035","article-title":"Systemic Sclerosis Dermal Fibroblasts Suppress Th1 Cytokine Production via Galectin-9 Overproduction due to Fli1 Deficiency","volume":"137","author":"Saigusa","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa052955","article-title":"Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis","volume":"354","author":"Baroni","year":"2006","journal-title":"N. Engl J. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/ard.2010.135772","article-title":"Involvement of functional autoantibodies against vascular receptors in systemic sclerosis","volume":"70","author":"Riemekasten","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar4457","article-title":"Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis","volume":"16","author":"Kill","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/ar4503","article-title":"Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients","volume":"16","author":"Kill","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1164\/rccm.201403-0442OC","article-title":"Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis","volume":"190","author":"Becker","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_112","first-page":"1268","article-title":"Localization of endothelin-1 and its binding sites in scleroderma skin","volume":"21","author":"Vancheeswaran","year":"1994","journal-title":"J. Rheumatol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1172\/JCI117154","article-title":"Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. Regulation by transforming growth factor-beta","volume":"93","author":"Rudnicka","year":"1994","journal-title":"J. Clin. Invest."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/1529-0131(200111)44:11<2665::AID-ART446>3.0.CO;2-S","article-title":"Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: Role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis","volume":"44","author":"Distler","year":"2001","journal-title":"Arthritis Rheum."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.humpath.2005.10.007","article-title":"The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis","volume":"37","author":"Davies","year":"2006","journal-title":"Hum. Pathol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/art.20883","article-title":"Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis","volume":"52","author":"Distler","year":"2005","journal-title":"Arthritis Rheum."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1038\/jid.2010.120","article-title":"Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis","volume":"130","author":"Aden","year":"2010","journal-title":"J. Investig. Dermatol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1038\/jid.2014.253","article-title":"Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S100A9","volume":"134","author":"Shiwen","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1093\/rheumatology\/kex280","article-title":"Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta","volume":"56","author":"McCoy","year":"2017","journal-title":"Rheumatology"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/jdv.14459","article-title":"A potential contribution of psoriasin to vascular and epithelial abnormalities and inflammation in systemic sclerosis","volume":"32","author":"Takahashi","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/exd.13900","article-title":"A potential contribution of decreased galectin-7 expression in stratified epithelia to the development of cutaneous and oesophageal manifestations in systemic sclerosis","volume":"28","author":"Saigusa","year":"2019","journal-title":"Exp. Dermatol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1084\/jem.20160247","article-title":"Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma","volume":"214","author":"Takahashi","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.21948","article-title":"Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts","volume":"54","author":"Wang","year":"2006","journal-title":"Arthritis Rheum."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1128\/MCB.01278-08","article-title":"Transcription factor Fli1 regulates collagen fibrillogenesis in mouse skin","volume":"29","author":"Asano","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3389\/fimmu.2020.00800","article-title":"Fli1 Downregulation in Scleroderma Myeloid Cells Has Profibrotic and Proinflammatory Effects","volume":"11","author":"Bujor","year":"2020","journal-title":"Front Immunol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/exd.13724","article-title":"CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis","volume":"27","author":"Taniguchi","year":"2018","journal-title":"Exp. Dermatol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1126\/science.1075958","article-title":"Projection of an immunological self shadow within the thymus by the aire protein","volume":"298","author":"Anderson","year":"2002","journal-title":"Science"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.immunol.25.022106.141532","article-title":"Aire","volume":"27","author":"Mathis","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrmicro.2017.157","article-title":"The human skin microbiome","volume":"16","author":"Byrd","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nrmicro2537","article-title":"The skin microbiome","volume":"9","author":"Grice","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13075-019-1816-z","article-title":"Microbiome dysbiosis is associated with disease duration and increased inflammatory gene expression in systemic sclerosis skin","volume":"21","author":"Johnson","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrrheum.2011.149","article-title":"Understanding fibrosis in systemic sclerosis: Shifting paradigms, emerging opportunities","volume":"8","author":"Bhattacharyya","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1172\/JCI93555","article-title":"Fibroblast heterogeneity: Implications for human disease","volume":"128","author":"Lynch","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Shao, M., Hepler, C., Zi, Z., Zhao, S., An, Y.A., Zhu, Y., Ghaben, A., Wang, M.Y., and Li, N. (2019). Dermal adipose tissue has high plasticity and undergoes reversible dedifferentiation in mice. J. Clin. Investig.","DOI":"10.1172\/JCI130239"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrrheum.2016.223","article-title":"Systemic sclerosis in 2016: Dermal white adipose tissue implicated in SSc pathogenesis","volume":"13","author":"Varga","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_136","first-page":"56","article-title":"Importance of adipocytokines in obesity-related diseases","volume":"60","author":"Matsuzawa","year":"2003","journal-title":"Horm. Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1468-3083.2011.04077.x","article-title":"Serum adiponectin levels inversely correlate with the activity of progressive skin sclerosis in patients with diffuse cutaneous systemic sclerosis","volume":"26","author":"Masui","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/s10165-012-0660-7","article-title":"Clinical significance of monitoring serum adiponectin levels during intravenous pulse cyclophosphamide therapy in interstitial lung disease associated with systemic sclerosis","volume":"23","author":"Masui","year":"2013","journal-title":"Mod. Rheumatol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/rheumatology\/ket010","article-title":"A possible contribution of visfatin to the resolution of skin sclerosis in patients with diffuse cutaneous systemic sclerosis via a direct anti-fibrotic effect on dermal fibroblasts and Th1 polarization of the immune response","volume":"52","author":"Masui","year":"2013","journal-title":"Rheumatology"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00296-013-2880-3","article-title":"Serum resistin levels: A possible correlation with pulmonary vascular involvement in patients with systemic sclerosis","volume":"34","author":"Masui","year":"2014","journal-title":"Rheumatol. Int."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1468-3083.2011.04413.x","article-title":"Clinical significance of serum retinol binding protein-4 levels in patients with systemic sclerosis","volume":"27","author":"Toyama","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1468-3083.2011.04354.x","article-title":"Serum apelin levels: Clinical association with vascular involvements in patients with systemic sclerosis","volume":"27","author":"Aozasa","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/bjd.13779","article-title":"A possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis","volume":"173","author":"Takahashi","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/1346-8138.12824","article-title":"Serum omentin levels: A possible contribution to vascular involvement in patients with systemic sclerosis","volume":"42","author":"Miura","year":"2015","journal-title":"J. Dermatol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/1346-8138.12810","article-title":"Serum vaspin levels: A possible correlation with digital ulcers in patients with systemic sclerosis","volume":"42","author":"Miura","year":"2015","journal-title":"J. Dermatol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1186\/ar3827","article-title":"Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: Potential utility as biomarker?","volume":"14","author":"Lakota","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cyto.2012.02.003","article-title":"Adiponectin relation to skin changes and dyslipidemia in systemic sclerosis","volume":"58","author":"Tomcik","year":"2012","journal-title":"Cytokine"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/j.1600-0625.2011.01310.x","article-title":"Adiponectin expression is decreased in the involved skin and sera of diffuse cutaneous scleroderma patients","volume":"20","author":"Arakawa","year":"2011","journal-title":"Exp. Dermatol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1038\/s41598-017-04162-1","article-title":"Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target","volume":"7","author":"Marangoni","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"11843","DOI":"10.1038\/s41598-018-29901-w","article-title":"An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis","volume":"8","author":"Yamashita","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00002281-199611000-00012","article-title":"Gastrointestinal features of scleroderma","volume":"8","author":"Sjogren","year":"1996","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_152","first-page":"30","article-title":"Gastrointestinal manifestations of progressive systemic scleroderma based on a review of 364 cases","volume":"58","author":"Poirier","year":"1972","journal-title":"Am. J. Gastroenterol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0889-857X(05)70302-1","article-title":"Gastrointestinal manifestations of scleroderma","volume":"22","author":"Young","year":"1996","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nrgastro.2016.99","article-title":"Current management of the gastrointestinal complications of systemic sclerosis","volume":"13","author":"Emmanuel","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_155","first-page":"763","article-title":"Gastrointestinal manifestations of progressive systemic sclerosis","volume":"92","author":"Lock","year":"1997","journal-title":"Am. J. Gastroenterol"},{"key":"ref_156","first-page":"1203","article-title":"Autonomic nervous system and smooth muscle cell involvement in systemic sclerosis: Ultrastructural study of 3 cases","volume":"27","author":"Malandrini","year":"2000","journal-title":"J. Rheumatol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/annrheumdis-2013-203889","article-title":"Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): Report from a single VEDOSS\/EUSTAR centre","volume":"74","author":"Lepri","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1572-0241.1998.00334.x","article-title":"Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders","volume":"93","author":"Weston","year":"1998","journal-title":"Am. J. Gastroenterol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1442-2050.2010.01150.x","article-title":"Esophageal dysmotility associated with systemic sclerosis: A high-resolution manometry study","volume":"24","author":"Roman","year":"2011","journal-title":"Dis. Esophagus"},{"key":"ref_160","first-page":"S15","article-title":"Assessment of gastrointestinal involvement","volume":"21","author":"Clements","year":"2003","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_161","first-page":"2692","article-title":"Twenty-four hour intraesophageal pH monitoring in children and adolescents with scleroderma and mixed connective tissue disease","volume":"27","author":"Weber","year":"2000","journal-title":"J. Rheumatol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0022-2143(99)90184-1","article-title":"Myenteric neuronal antibodies in scleroderma: Passive transfer evokes alterations in intestinal myoelectric activity in a rat model","volume":"133","author":"Eaker","year":"1999","journal-title":"J. Lab. Clin. Med."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/ard.2008.096545","article-title":"Muscarinic-3 acetylcholine receptor autoantibody in patients with systemic sclerosis: Contribution to severe gastrointestinal tract dysmotility","volume":"68","author":"Kawaguchi","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"G1206","DOI":"10.1152\/ajpgi.00286.2009","article-title":"Immunoglobulins from scleroderma patients inhibit the muscarinic receptor activation in internal anal sphincter smooth muscle cells","volume":"297","author":"Singh","year":"2009","journal-title":"Am. J. Physiol. Gastrointest Liver Physiol."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Kafaja, S., Valera, I., Divekar, A.A., Saggar, R., Abtin, F., Furst, D.E., Khanna, D., and Singh, R.R. (2018). pDCs in lung and skin fibrosis in a bleomycin-induced model and patients with systemic sclerosis. JCI Insight, 3.","DOI":"10.1172\/jci.insight.98380"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1023\/A:1020536815573","article-title":"Esophageal striated muscle contractions in patients with gastroesophageal reflux symptoms","volume":"47","author":"Dantas","year":"2002","journal-title":"Dig. Dis. Sci."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/MOG.0000000000000282","article-title":"Gastroesophageal reflux disease-related and functional heartburn: Pathophysiology and treatment","volume":"32","author":"Miwa","year":"2016","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0002-9343(92)90043-B","article-title":"Autonomic dysfunction in systemic sclerosis: Sympathetic overactivity and instability","volume":"93","author":"Dessein","year":"1992","journal-title":"Am. J. Med."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10067-017-3821-4","article-title":"The role of gut microbiota in the pathogenesis of rheumatic diseases","volume":"37","author":"Zhong","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"ref_170","first-page":"74","article-title":"The microbiome in autoimmune diseases","volume":"195","author":"Shoenfeld","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaut.2016.06.009","article-title":"A clinical update on the significance of the gut microbiota in systemic autoimmunity","volume":"74","author":"Rosser","year":"2016","journal-title":"J. Autoimmun"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11926-018-0758-9","article-title":"Update on the Gastrointestinal Microbiome in Systemic Sclerosis","volume":"20","author":"Bellocchi","year":"2018","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/BOR.0000000000000429","article-title":"Intestinal microbiome in scleroderma: Recent progress","volume":"29","author":"Volkmann","year":"2017","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/art.10775","article-title":"Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement","volume":"48","author":"Steen","year":"2003","journal-title":"Arthritis Rheum."},{"key":"ref_177","first-page":"175","article-title":"Pulmonary veno-occlusive disease: A rare cause of pulmonary hypertension in systemic sclerosis. Case presentation and review of the literature","volume":"53","author":"Daraban","year":"2015","journal-title":"Rom. J. Intern. Med."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Duarte, A.C., Cordeiro, A., Loureiro, M.J., and Ferreira, F. (2020). Pulmonary veno-occlusive disease: A probably underdiagnosed cause of pulmonary hypertension in systemic sclerosis. Clin. Rheumatol.","DOI":"10.1007\/s10067-020-04953-4"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/acr.21583","article-title":"Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis","volume":"64","author":"Steele","year":"2012","journal-title":"Arthritis Care Res."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0889-857X(03)00025-5","article-title":"Interstitial lung disease in scleroderma","volume":"29","author":"White","year":"2003","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/art.38390","article-title":"Prediction of pulmonary complications and long-term survival in systemic sclerosis","volume":"66","author":"Nihtyanova","year":"2014","journal-title":"Arthritis Rheum."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1002\/art.34482","article-title":"A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis","volume":"64","author":"Steen","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Jaeger, V.K., Wirz, E.G., Allanore, Y., Rossbach, P., Riemekasten, G., Hachulla, E., Distler, O., Airo, P., Carreira, P.E., and Balbir Gurman, A. (2016). Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0163894"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10067-005-0041-0","article-title":"Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis","volume":"25","author":"Ostojic","year":"2006","journal-title":"Clin. Rheumatol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1523-1747.2003.12028.x","article-title":"The prevalence and clinical significance of anti-U1 RNA antibodies in patients with systemic sclerosis","volume":"120","author":"Asano","year":"2003","journal-title":"J. Investig. Dermatol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/rheumatology\/kev016","article-title":"Changes in forced vital capacity over time in systemic sclerosis: Application of group-based trajectory modelling","volume":"54","author":"Man","year":"2015","journal-title":"Rheumatology"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/art.1780370903","article-title":"Severe restrictive lung disease in systemic sclerosis","volume":"37","author":"Steen","year":"1994","journal-title":"Arthritis Rheum."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/ard.62.2.146","article-title":"Predictors of end stage lung disease in a cohort of patients with scleroderma","volume":"62","author":"Morgan","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1164\/rccm.2106012","article-title":"Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome","volume":"165","author":"Bouros","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_190","first-page":"121","article-title":"The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia","volume":"19","author":"Kim","year":"2002","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1378\/chest.08-0053","article-title":"Clinically significant interstitial lung disease in limited scleroderma: Histopathology, clinical features, and survival","volume":"134","author":"Fischer","year":"2008","journal-title":"Chest"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1378\/chest.13-2626","article-title":"Predictors of mortality and progression in scleroderma-associated interstitial lung disease: A systematic review","volume":"146","author":"Winstone","year":"2014","journal-title":"Chest"},{"key":"ref_193","first-page":"733","article-title":"Myofibroblast induction and microvascular alteration in scleroderma lung fibrosis","volume":"22","author":"Beon","year":"2004","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1164\/rccm.200808-1359OC","article-title":"Gastroesophageal reflux and pulmonary fibrosis in scleroderma: A study using pH-impedance monitoring","volume":"179","author":"Savarino","year":"2009","journal-title":"Am. J. Respir Crit Care Med."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1465-9921-8-87","article-title":"Characterization of the innate immune response to chronic aspiration in a novel rodent model","volume":"8","author":"Appel","year":"2007","journal-title":"Respir. Res."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.semarthrit.2010.03.002","article-title":"Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: Clinical, radiologic, histopathologic, and treatment evidence","volume":"40","author":"Christmann","year":"2010","journal-title":"Semin Arthritis Rheum."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000156958","article-title":"Centrilobular fibrosis: An underrecognized pattern in systemic sclerosis","volume":"77","author":"Borges","year":"2009","journal-title":"Respiration"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/art.38942","article-title":"Cardiomyopathy in murine models of systemic sclerosis","volume":"67","author":"Venalis","year":"2015","journal-title":"Arthritis Rheum."},{"key":"ref_199","first-page":"S48","article-title":"Primary myocardial involvement in systemic sclerosis: Evidence for a microvascular origin","volume":"28","author":"Allanore","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1136\/ard.2008.095836","article-title":"Cardiac magnetic resonance imaging in systemic sclerosis: A cross-sectional observational study of 52 patients","volume":"68","author":"Hachulla","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/ard.57.11.682","article-title":"Mortality and causes of death in a Swedish series of systemic sclerosis patients","volume":"57","author":"Hesselstrand","year":"1998","journal-title":"Ann. Rheum. Dis."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.amjmed.2004.04.031","article-title":"Mortality in systemic sclerosis: An international meta-analysis of individual patient data","volume":"118","author":"Ioannidis","year":"2005","journal-title":"Am. J. Med."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","article-title":"Severe organ involvement in systemic sclerosis with diffuse scleroderma","volume":"43","author":"Steen","year":"2000","journal-title":"Arthritis Rheum."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"iii45","DOI":"10.1093\/rheumatology\/kep110","article-title":"Cardiac complications of systemic sclerosis","volume":"48","author":"Kahan","year":"2009","journal-title":"Rheumatology"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"v51","DOI":"10.1093\/rheumatology\/ken268","article-title":"Outcome measures for heart involvement in systemic sclerosis","volume":"47","author":"Allanore","year":"2008","journal-title":"Rheumatology"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-200203000-00004","article-title":"Systemic sclerosis: Demographic, clinical, and serologic features and survival in 1,012 Italian patients","volume":"81","author":"Ferri","year":"2002","journal-title":"Medicine"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.53.3.483","article-title":"Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction","volume":"53","author":"Bulkley","year":"1976","journal-title":"Circulation"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/rheumatology\/ken186","article-title":"Myocardial involvement in systemic sclerosis","volume":"47","author":"Belloli","year":"2008","journal-title":"Rheumatology"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/BOR.0b013e32834b8975","article-title":"Systemic sclerosis and the heart: Current diagnosis and management","volume":"23","author":"Desai","year":"2011","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1002\/art.22971","article-title":"Pattern and distribution of myocardial fibrosis in systemic sclerosis: A delayed enhanced magnetic resonance imaging study","volume":"56","author":"Tzelepis","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_211","first-page":"1941","article-title":"High prevalence of right ventricular systolic dysfunction in early systemic sclerosis","volume":"31","author":"Meune","year":"2004","journal-title":"J. Rheumatol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/clpt.1990.61","article-title":"The effect of captopril on thallium 201 myocardial perfusion in systemic sclerosis","volume":"47","author":"Kahan","year":"1990","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/art.1780340211","article-title":"The effect of nifedipine on myocardial perfusion and metabolism in systemic sclerosis. A positron emission tomographic study","volume":"34","author":"Duboc","year":"1991","journal-title":"Arthritis Rheum."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00005344-199002000-00011","article-title":"Pharmacodynamic effect of nicardipine on left ventricular function in systemic sclerosis","volume":"15","author":"Kahan","year":"1990","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_215","first-page":"135","article-title":"Cold-induced coronary Raynaud\u2019s phenomenon in patients with systemic sclerosis","volume":"16","author":"Lekakis","year":"1998","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"976427","DOI":"10.1155\/2011\/976427","article-title":"Primary biliary cirrhosis associated with systemic sclerosis: Diagnostic and clinical challenges","volume":"2011","author":"Rigamonti","year":"2011","journal-title":"Int. J. Rheumatol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13317-011-0023-y","article-title":"Towards systemic sclerosis and away from primary biliary cirrhosis: The case of PTPN22","volume":"3","author":"Smyk","year":"2012","journal-title":"Auto. Immun. Highlights"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3109\/s10165-012-0607-z","article-title":"High prevalence of primary biliary cirrhosis and disease-associated autoantibodies in Japanese patients with systemic sclerosis","volume":"22","author":"Hasegawa","year":"2012","journal-title":"Mod. Rheumatol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/0377-4929.77319","article-title":"Liver pathology in collagen vascular disorders highlighting the vascular changes within portal tracts","volume":"54","author":"Vaiphei","year":"2011","journal-title":"Indian J. Pathol. Microbiol"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3748\/wjg.v17.i11.1400","article-title":"Nodular regenerative hyperplasia: Evolving concepts on underdiagnosed cause of portal hypertension","volume":"17","author":"Hartleb","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"ref_221","first-page":"1425","article-title":"Nodular regenerative hyperplasia of the liver. A review of 14 cases","volume":"48","author":"Arvanitaki","year":"2001","journal-title":"Hepatogastroenterology"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3899\/jrheum.170292","article-title":"Nodular Regenerative Hyperplasia of the Liver: A Rare Vascular Complication in Systemic Sclerosis","volume":"45","author":"Graf","year":"2018","journal-title":"J. Rheumatol."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/s10165-006-0504-4","article-title":"Scleroderma renal crisis in a patient with anticentromere antibody-positive limited cutaneous systemic sclerosis","volume":"16","author":"Sugimoto","year":"2006","journal-title":"Mod. Rheumatol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1440-1797.2007.00892.x","article-title":"Is scleroderma renal crisis with anti-centromere antibody-positive limited cutaneous systemic sclerosis overlooked in patients with hypertension and\/or renal dysfunction?","volume":"13","author":"Sugimoto","year":"2008","journal-title":"Nephrology"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/clin.1998.4591","article-title":"Analysis of autoantibodies against RNA polymerases using immunoaffinity-purifed RNA polymerase I, II, and III antigen in an enzyme-linked immunosorbent assay","volume":"89","author":"Chang","year":"1998","journal-title":"Clin. Immunol. Immunopathol."},{"key":"ref_226","first-page":"1528","article-title":"Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA","volume":"34","author":"Santiago","year":"2007","journal-title":"J. Rheumatol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin Arthritis Rheum."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"iii32","DOI":"10.1093\/rheumatology\/ken483","article-title":"Renal complications and scleroderma renal crisis","volume":"48","author":"Denton","year":"2009","journal-title":"Rheumatology"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O","article-title":"Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis","volume":"41","author":"Steen","year":"1998","journal-title":"Arthritis Rheum."},{"key":"ref_230","first-page":"135","article-title":"Effect of dihydropyridine calcium channel blockers and glucocorticoids on the prevention and development of scleroderma renal crisis in an Italian case series","volume":"31","author":"Montanelli","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.semarthrit.2013.09.008","article-title":"Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the International Scleroderma Renal Crisis Survey","volume":"43","author":"Hudson","year":"2014","journal-title":"Semin Arthritis Rheum."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3109\/08860229809045170","article-title":"Normotensive scleroderma renal crisis: Case report and review of the literature","volume":"20","author":"Haviv","year":"1998","journal-title":"Ren. Fail."},{"key":"ref_233","first-page":"294","article-title":"Kidney crisis in systemic sclerosis","volume":"50","author":"Lewandowski","year":"2005","journal-title":"Rocz. Akad. Med. Bialymst."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/anr.1780320911","article-title":"Normotensive renal failure in systemic sclerosis","volume":"32","author":"Helfrich","year":"1989","journal-title":"Arthritis Rheum."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrneph.2016.124","article-title":"Scleroderma renal crisis and renal involvement in systemic sclerosis","volume":"12","author":"Woodworth","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.humpath.2008.08.001","article-title":"Renal biopsy findings predicting outcome in scleroderma renal crisis","volume":"40","author":"Batal","year":"2009","journal-title":"Hum. Pathol."},{"key":"ref_237","first-page":"29","article-title":"Pathologic observations concerning the kidney in progressive systemic sclerosis","volume":"65","author":"Fisher","year":"1958","journal-title":"AMA Arch. Pathol."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12016-009-8191-5","article-title":"Scleroderma renal crisis: A rare but severe complication of systemic sclerosis","volume":"40","author":"Mouthon","year":"2011","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/art.1780310311","article-title":"Renal vascular histology and morphometry in systemic sclerosis. A case-control autopsy study","volume":"31","author":"Trostle","year":"1988","journal-title":"Arthritis Rheum."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1016\/j.lpm.2014.02.031","article-title":"Kidney involvement in systemic sclerosis","volume":"43","author":"Steen","year":"2014","journal-title":"Presse. Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/9\/2687\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:03:17Z","timestamp":1760176997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/9\/2687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,19]]},"references-count":240,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["jcm9092687"],"URL":"https:\/\/doi.org\/10.3390\/jcm9092687","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,19]]}}}